CD8A and ovarian carcinoma: Moreover, in ovarian cancer, antigen-experienced CD20+ B cells colocalized with activated CD8+ T cells, and the presence of both populations correlated with increased patient survival compared with the presence of CD8+ T cells alone (Nielsen et al., 2012).